Skip to main content

Anastrozole News

Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years

FRIDAY, June 20, 2025 – Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy, according to a study published recently in JNCI:...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Breast Cancer, Metastatic, Endometrial Cancer

Related drug support groups

Arimidex

Anastrozole patient information at Drugs.com